Nomura Holdings Inc. Invests $395,000 in Amedisys, Inc. (NASDAQ:AMED)

Nomura Holdings Inc. acquired a new position in shares of Amedisys, Inc. (NASDAQ:AMED - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 4,346 shares of the health services provider's stock, valued at approximately $395,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in AMED. Norges Bank acquired a new stake in shares of Amedisys during the 4th quarter worth approximately $83,061,000. Wealthfront Advisers LLC acquired a new stake in Amedisys in the 4th quarter valued at $72,970,000. Pentwater Capital Management LP grew its stake in Amedisys by 178.3% in the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider's stock valued at $107,132,000 after acquiring an additional 756,000 shares during the period. Pacer Advisors Inc. grew its stake in Amedisys by 11,621.9% in the 4th quarter. Pacer Advisors Inc. now owns 558,197 shares of the health services provider's stock valued at $50,679,000 after acquiring an additional 553,435 shares during the period. Finally, AQR Arbitrage LLC grew its stake in Amedisys by 59.1% in the 4th quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider's stock valued at $42,812,000 after acquiring an additional 175,311 shares during the period. Institutional investors and hedge funds own 94.36% of the company's stock.

Amedisys Price Performance

AMED traded up $0.56 on Tuesday, hitting $93.99. 205,629 shares of the company's stock were exchanged, compared to its average volume of 417,095. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $98.95. The company has a current ratio of 1.19, a quick ratio of 1.19 and a debt-to-equity ratio of 0.05. The firm has a 50-day moving average price of $93.39 and a 200-day moving average price of $91.52. The stock has a market cap of $3.08 billion, a price-to-earnings ratio of 37.30, a P/E/G ratio of 1.78 and a beta of 0.96.

Amedisys (NASDAQ:AMED - Get Free Report) last announced its earnings results on Wednesday, April 23rd. The health services provider reported $1.25 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.13 by $0.12. Amedisys had a net margin of 3.57% and a return on equity of 12.20%. The company had revenue of $594.78 million for the quarter, compared to analysts' expectations of $597.43 million. During the same quarter in the previous year, the company posted $1.03 EPS. The firm's quarterly revenue was up 4.1% on a year-over-year basis. As a group, equities analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on the stock. Royal Bank of Canada reissued an "outperform" rating and issued a $100.00 price target on shares of Amedisys in a research note on Wednesday, April 16th. Wall Street Zen cut shares of Amedisys from a "strong-buy" rating to a "buy" rating in a research note on Saturday. Finally, Stephens reissued an "equal weight" rating and issued a $101.00 price target on shares of Amedisys in a research note on Tuesday, March 4th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. According to data from MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $100.75.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.